Nautilus Biotechnolgy

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAUT and other ETFs, options, and stocks.

About NAUT

Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. 

CEO
Sujal M. Patel
CEOSujal M. Patel
Employees
155
Employees155
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2016
Founded2016
Employees
155
Employees155

NAUT Key Statistics

Market cap
95.87M
Market cap95.87M
Price-Earnings ratio
-1.46
Price-Earnings ratio-1.46
Dividend yield
Dividend yield
Average volume
160.43K
Average volume160.43K
High today
$0.77
High today$0.77
Low today
$0.7384
Low today$0.7384
Open price
$0.77
Open price$0.77
Volume
139.79K
Volume139.79K
52 Week high
$3.09
52 Week high$3.09
52 Week low
$0.66
52 Week low$0.66

People also own

Based on the portfolios of people who own NAUT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.